looking forward to some clarity on the quarterly call.
looking forward to some clarity on the quarterly call.
such a bizarre, long-term experience, at least for me. on the one-hand, it's really exciting to hear about these great things our drug can do. on the other, it's incredibly frustrating that none of them are able to get any traction - nor have they been able to for years. and as we read in the news, research / new treatments are advancing rapidly - and i can only assume AI will further accelerate the discovery of new compounds. it's like having a tricked out ski boat, but the engine isn't working. you're sitting in the middle of the lake stalled out, while lesser boats cruise by. technical specs of low wind drag, turning radius, etc. of your boat can only give so much consolation as you sit in the middle of the lake.
personally, i am hoping for some solution that's very different from the long-term build out here. whether it's Cyrus or someone else, can we get creative about monetizing this compound? personally, i'd take less money now, than multiple more years here for more money. i've just got other things i need to do, and my money has been tied up way too long now. i know some disagree - and that's fine. if i were just buying in at .25 and brand new as an investor, i'd be gung ho for a 5-10 year run also.
hoping (praying?) that this next call provides some clarity about how we can finally get something going here.
18
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Investors Encouraged to Act Before Class Action Deadline WPP plc is making headlines as investors are reminded of the critical timelines regarding a securities class action lawsuit. If you purchased American Depositary Shares (ADS) for WPP plc within a specific class period earlier this year, know that you have the opportunity to join a lawsuit that could secure...
Continue Reading
Insights into the HER2-Positive Gastric Cancer Landscape The HER2-positive gastric cancer market is on the rise, fueled by an increasing number of patients who can benefit from targeted treatments. This surge results from heightened global disease prevalence and advancements in HER2 testing. As a result, more patients are being identified as candidates for therapies...
Continue Reading
Revolutionizing a Fragmented Entertainment Industry Tradewinds Universal, Inc. (OTC: TRWD) stands at the brink of transformation within a significant and fragmented entertainment landscape. This sector includes over 3,000 independently owned venues, contributing to a market size that exceeds $10 billion annually. With these numbers indicating a ripe opportunity, TRWD...
Continue Reading
Understanding Whales' Strategies in Rivian Automotive Options Recent actions by financial giants have signaled a notable bearish trend towards Rivian Automotive (NASDAQ: RIVN). A thorough analysis of options trading activity reveals intriguing insights into how these major players are approaching the market. In our study, we uncovered nine unusual trades that exemplify...
Continue Reading
Fortive Corporation Announces New Chair of the Board Fortive Corporation (NYSE: FTV) has made an important announcement regarding its Board of Directors. The company has appointed Sharmistha "Shar" Dubey as the new Chair of the Board, succeeding Alan G. Spoon. This transition comes as Spoon has decided to retire and not seek reelection at the upcoming Annual General...
Continue Reading